Kore Private Wealth’s Heron Therapeutics HRTX Stock Holding History

Kore Private Wealth’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,000	Closed	-$24K	–	480
2019 Q1	$24K	Hold	1,000	–	–	0.01%	487
2018 Q4	$26K	Buy	+1,000	New	+$27.5K	0.01%	459

Other funds holding HRTX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Kore Private Wealth's HRTX Position: Q2 2019 in Review

Kore Private Wealth sold out of Heron Therapeutics (HRTX) in Q2 2019, closing a stake of 1,000 shares — an estimated $24K sold.

Kore Private Wealth first reported a position in HRTX in Q4 2018 and held it in 2 quarters. The position peaked at $26K in Q4 2018. 176 funds tracked by Wall St. Rank hold HRTX as of Q2 2019.

Kore Private Wealth reported no remaining Heron Therapeutics position as of Q2 2019 after selling out during the quarter.
Kore Private Wealth sold 1,000 Heron Therapeutics shares in Q2 2019, an estimated $24K.
Kore Private Wealth first reported a position in Heron Therapeutics in Q4 2018 and held it in 2 quarters.
Kore Private Wealth's Heron Therapeutics position peaked at $26K in Q4 2018.
176 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2019.

Based on Kore Private Wealth's 13F filing for Q2 2019, filed 14 Aug 2019.